Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence.
Andrews CN, Rehak R, Woo M, Walker I, Ma C, Forbes N, Rittenbach K, Hathaway J, Wilsack L, Liu A, Nasser Y, Sharkey KA.
Andrews CN, et al. Among authors: sharkey ka.
Aliment Pharmacol Ther. 2022 Dec;56(11-12):1532-1542. doi: 10.1111/apt.17265. Epub 2022 Oct 28.
Aliment Pharmacol Ther. 2022.
PMID: 36307209